Gene expression profiling of human macrophages after graphene oxide and graphene nanoplatelets treatment reveals particle-specific regulation of pathways.

Graphene-related materials In vitro toxicity Lung Macrophages Transcriptomics

Journal

NanoImpact
ISSN: 2452-0748
Titre abrégé: NanoImpact
Pays: Netherlands
ID NLM: 101676795

Informations de publication

Date de publication:
01 2023
Historique:
received: 11 08 2022
revised: 09 12 2022
accepted: 19 01 2023
pubmed: 31 1 2023
medline: 8 3 2023
entrez: 30 1 2023
Statut: ppublish

Résumé

Graphene and its derivatives are attractive materials envisaged to enable a wealth of novel applications in many fields including energy, electronics, composite materials or health. A comprehensive understanding of the potential adverse effects of graphene-related materials (GRM) in humans is a prerequisite to the safe use of these promising materials. Here, we exploited gene expression profiling to identify transcriptional responses and toxicity pathways induced by graphene oxide (GO) and graphene nanoplatelets (GNP) in human macrophages. Primary human monocyte-derived macrophages (MDM) and a human macrophage cell line, i.e. differentiated THP-1 cells, were exposed to 5 or 20 μg/mL GO and GNP for 6 and 24 h to capture early and more persistent acute responses at realistic or slightly overdose concentrations. GO and GNP induced time-, dose- and macrophage type-specific differential expression of a substantial number of genes with some overlap between the two GRM types (up to 384 genes (9.6%) or 447 genes (20.4%) in THP-1 or MDM, respectively) but also a high number of genes exclusively deregulated from each material type. Furthermore, GRM responses on gene expression were highly different from those induced by inflammogenic material crystalline quartz (maximum of 64 (2.3%) or 318 (11.3%) common genes for MDM treated with 20 μg/mL GO and GNP, respectively). Further bioinformatics analysis revealed that GNP predominantly activated genes controlling inflammatory and apoptotic pathways whereas GO showed only limited inflammatory responses. Interestingly, both GRM affected the expression of genes related to antigen processing and presentation and in addition, GO activated pathways of neutrophil activation, degranulation and immunity in MDM. Overall, this study provides an extensive resource of potential toxicity mechanisms for future safety assessment of GRM in more advanced model systems to verify if the observed changes in gene expression in human macrophages could lead to long-term consequences on human health.

Identifiants

pubmed: 36717017
pii: S2452-0748(23)00003-4
doi: 10.1016/j.impact.2023.100452
pii:
doi:

Substances chimiques

graphene oxide 0
Graphite 7782-42-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100452

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Daria Korejwo (D)

Particles-Biology Interactions Lab, Empa, Swiss Federal Laboratories for Materials Science and Technology, 9014 St. Gallen, Switzerland; Adolphe Merkle Institute, University of Fribourg, 1700 Fribourg, Switzerland.

Savvina Chortarea (S)

Particles-Biology Interactions Lab, Empa, Swiss Federal Laboratories for Materials Science and Technology, 9014 St. Gallen, Switzerland.

Chrysovalanto Louka (C)

Particles-Biology Interactions Lab, Empa, Swiss Federal Laboratories for Materials Science and Technology, 9014 St. Gallen, Switzerland.

Marija Buljan (M)

Particles-Biology Interactions Lab, Empa, Swiss Federal Laboratories for Materials Science and Technology, 9014 St. Gallen, Switzerland.

Barbara Rothen-Rutishauser (B)

Adolphe Merkle Institute, University of Fribourg, 1700 Fribourg, Switzerland.

Peter Wick (P)

Particles-Biology Interactions Lab, Empa, Swiss Federal Laboratories for Materials Science and Technology, 9014 St. Gallen, Switzerland.

Tina Buerki-Thurnherr (T)

Particles-Biology Interactions Lab, Empa, Swiss Federal Laboratories for Materials Science and Technology, 9014 St. Gallen, Switzerland. Electronic address: tina.buerki@empa.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH